Antibody

1,020개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,020 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleADC TherapeuticsPhase 1

durvalumab (Imfinzi, Loncastuximab Tesirine and Durvalumab)

Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase1#monoclonal-antibody#MantleCellLymphoma+1
Trials 1Status Discontinued
AntibodyLimited DatastaleBayerPhase 1

BAY1129980 (Lupartumab Amadotin, Lupartumab Amadotin (BAY1129980))

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#Bayer
Trials 1Status Discontinued
AntibodyLimited DatastaleBond Avillion 2 Development LPPhase 2

Sonelokimab (M1095, M1095 (Sonelokimab))

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase2#monoclonal-antibody#Bond
Trials 1Status Active
AntibodyLimited DatastaleEvangelos J. Giamarellos-Bourbo…Phase 2

MABp1 (MABp1)

Hidradenitis Suppurativa · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#monoclonal-antibody#Evangelos
Trials 1Status Active
AntibodyLimited DatastaleIRCCS National Neurological Ins…Preclinical

MAbs (MAbs)

Migraine Disorders; Chronic Migraine · Migraine Disorders

#MigraineDisorders#Antibody#Preclinical#monoclonal-antibody#ChronicMigraine+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Bevacizumab Biosimilar Drug (MB02, MB02 (Bevacizumab Biosimilar Drug))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastalemAbxience Research S.L.Phase 1

Bevacizumab Biosimilar (MB02, MB02 (Bevacizumab Biosimilar))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#monoclonal-antibody#mAbxience
Trials 1Status Active
AntibodyLimited DatastaleMerus B.V.Phase 2

pembrolizumab (Keytruda, MCLA-158 + Pembrolizumab)

Advanced/Metastatic Solid Tumors; Colorectal Cancer · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#Antibody#Phase2#monoclonal-antibody#Advanced+3
Trials 1Status Recruiting
AntibodyLimited DatastaleMedImmune LLCPhase 2

durvalumab (Imfinzi, MEDI6469 Plus Durvalumab)

Advanced Solid Tumors; Aggressive B-cell Lymphomas · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#monoclonal-antibody#AggressiveB-cellLymphomas+1
Trials 1Status Discontinued
AntibodyLimited DatastaleMedImmune LLCPhase 2

MEDI6469 Plus Tremelimumab (MEDI6469 Plus Tremelimumab)

Advanced Solid Tumors; Aggressive B-cell Lymphomas · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#monoclonal-antibody#AggressiveB-cellLymphomas+1
Trials 1Status Discontinued
AntibodyLimited DatastaleMedImmune LLCPhase 2

MEDI6469 plus Rituximab (MEDI6469 plus Rituximab)

Advanced Solid Tumors; Aggressive B-cell Lymphomas · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#monoclonal-antibody#AggressiveB-cellLymphomas+1
Trials 1Status Discontinued
AntibodyLimited DatastaleMedivirPhase 2

pembrolizumab (Keytruda, MIV-818, MIV-818 (fostroxacitabine bralpamide) + pembrolizumab, fostroxacitabine bralpamide)

Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#IntrahepaticCholangiocarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleCentre Hospitalier Universitair…Phase 2

durvalumab (Imfinzi, MP0317 + Gemcitabine + Cisplatine + Durvalumab)

Advanced Biliary Tract Carcinoma · Advanced Biliary Tract Carcinoma

#AdvancedBiliaryTractCarcinoma#Antibody#Phase2#monoclonal-antibody#Centre
Trials 1Status Recruiting
AntibodyLimited DatastaleMonopteros Therapeutics Inc.Phase 1

pembrolizumab (Keytruda, MPT-0118 + pembrolizumab)

Solid Tumor, Adult; Advanced Solid Tumor · FRα

#FR#Antibody#Phase1#monoclonal-antibody#SolidTumor+3
Trials 1Status Active
AntibodyLimited DatastaleLei LiuPhase 2

MRG003 combined with Pucotenlimab (MRG003 combined with Pucotenlimab)

Head and Neck Squamous Cell Carcinoma (HNSCC) · Head and Neck Squamous Cell Carcinoma (H

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Lei
Trials 1Status Recruiting
AntibodyLimited DatastaleLei LiuPhase 2

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

Head and Neck Squamous Cell Carcinoma (HNSCC) · Head and Neck Squamous Cell Carcinoma (H

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Lei
Trials 1Status Recruiting
AntibodyLimited DatastaleMyeloid TherapeuticsPhase 1

atezolizumab (Tecentriq, MT-303 +Atezolizumab + Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase1#monoclonal-antibody#Myeloid
Trials 1Status Recruiting
AntibodyLimited DatastalePresage BiosciencesPhase 1

nivolumab (Opdivo, MVC-101 + Nivolumab)

Solid Tumour · Solid Tumour

#SolidTumour#Antibody#Phase1#monoclonal-antibody#Presage
Trials 1Status Discontinued
AntibodyLimited DatastaleTongji HospitalPreclinical

Mab Therapy (Mab Therapy)

NMO Spectrum Disorder · NMO Spectrum Disorder

#NMOSpectrumDisorder#Antibody#Preclinical#monoclonal-antibody#Tongji
Trials 1Status Recruiting
AntibodyLimited DatastaleInstitute for Clinical and Expe…Preclinical

MabCampath, (MabCampath,)

Kidney Transplantation · Kidney Transplantation

#KidneyTransplantation#Antibody#Preclinical#monoclonal-antibody#Institute
Trials 1Status Active

32 / 51 pages

← PreviousNext →